HOME › DRUGS › ERTUGLIFLOZIN
ACTIVE SUBSTANCE / INN

ERTUGLIFLOZIN

Brand name(s): STEGLATRO, SEGLUROMET, Steglatro, ERTUGLIFLOZIN, STEGLUJAN
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
NDA209803
NDA209805
ACTIVE SUBSTANCE
Ertugliflozin
REGULATORS
FDA · EMA
SPONSORS / MAH
HETERO LABS LTD V, MSD SUB MERCK, Merck Sharp & Dohme B.V.
TOTAL APPLICATIONS
5
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
STEGLUJANNDA209805MSD SUB MERCKPrescription
ERTUGLIFLOZINANDA217071HETERO LABS LTD VDiscontinued
STEGLATRONDA209803MSD SUB MERCKPrescription
SEGLUROMETNDA209806MSD SUB MERCKPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
SteglatroMerck Sharp & Dohme B.V.Authorised21/03/2018Diabetes Mellitus, Type 2

FULL INTELLIGENCE ON ERTUGLIFLOZIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →